Anbio Biotechnology (NNNN) Stock

Healthcare · Medical Instruments & Supplies · Member of Other US Stocks

Anbio Biotechnology (NNNN) closed at USD 3.57 on 2026-10-14, a change of -84.7 % over the past year, with a market capitalization of USD 144.84M.

Anbio Biotechnology recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Anbio Biotechnology key figures

Previous close

USD 3.57 (2026-10-14)

1-year change

-84.7 %

Market cap

USD 144.84M

Enterprise value

USD 132.94M

P/E ratio (trailing)

27.50

P/E ratio (forward)

n/a

EPS (trailing)

0.12

EPS (forward)

n/a

PEG ratio

n/a

Price to book

4.80

Revenue growth

73.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.23

Employees

27

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Anbio Biotechnology

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Anbio Biotechnology and compare it with other stocks.